(Q30887180)

27 June 2017

1 reference

title

Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease (English)

1 reference

27 June 2017

0 references

Carol Y Chang

1

1 reference

27 June 2017

Daniel H S Silverman

series ordinal

2

1 reference

27 June 2017

language of work or name

1 reference

1 January 2004

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

27 June 2017

published in

1 reference

27 June 2017

volume

4

1 reference

27 June 2017

issue

1

1 reference

27 June 2017

page(s)

63-69

1 reference

Estimated prevalence of Alzheimer's disease in the United States

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Neuroimaging and early diagnosis of Alzheimer disease: a look to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Effect of a training programme to reduce stress in carers of patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.4.1.63

21 January 2018

Identifiers

DOI

10.1586/14737159.4.1.63

1 reference

release_cewc6vhnqbhx5ihirfuzqqdymi

27 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cewc6vhnqbhx5ihirfuzqqdymi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference